Externally Funded Projects

2017-2020: The Research Council of Norway. FRIMEDBIO program. Optimized activation of tumor-associated macrophages as a novel strategy for cancer immunotherapy

2018-2021: Helse Sør-Øst. A novel strategy for cancer vaccine based on optimized activation of dendritic cells. (Applicant: I. Øynebråten)

2019-2022   Norwegian Cancer Society. Using type I and type II interferons for cancer immunotherapy.

2019-2023   Helse Sør-Øst. Adoptive transfer of engineered macrophages, as a novel tool for cancer immunotherapy (Applicant: P. Christopoulos)

International Collaborations

  • Institut Pasteur, Paris, France: V. Meas-Yedid, Jean-Christophe Olivo-Marin
  • Biomedical Research and Study Centre, Riga, Latvia: Anna Zajakina
  • Juntendo University School of Medicine, Tokyo, Japan: Hideo Jagita
  • University of California, San Francisco (UCSF), USA: Lewis lanier
Page visits: 622